Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.2400 (0%) ($22.9000 - $23.8200) on Wed. Apr. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 85 | Latest Price | $23.2400(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.8% a day on average for past five trading days. | Weekly Trend | HALO advances 13.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) ARKG(44%) IWM(44%) IWC(43%) | Factors Impacting HALO price | HALO will decline at least -2.09% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-14%) TLT(-3%) IYT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
5 Day Moving Average | $23.06(0.78%) | 10 Day Moving Average | $21.47(8.24%) | 20 Day Moving Average | $19.49(19.24%) | To recent high | -0.8% | To recent low | 67.2% | Market Cap | $3.176b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |